Brief: Heat Biologics Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
27/05/2020 13:38
May 27 (Reuters) - Heat Biologics Inc HTBX.O :
* HEAT BIOLOGICS INC - COLLABORATING WITH WAISMAN
BIOMANUFACTURING
TO ESTABLISH A PARTNERSHIP FOR MANUFACTURE OF CO'S COVID-19
VACCINE
Source text for Eikon: ID:nNDL5SNjrG
Further company coverage: HTBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Scorpius Holdings
See all newsBrief: Scorpius Holdings Inc Files For Non Timely 10-K With U.S. SEC
Brief: Scorpius Holdings Files For Offering Up To 29.4 Million Shares Of Common Stock
Brief: Scorpius Holdings Announces Collaboration With Celltheon Corporation
Brief: Scorpius Holdings - Implementation Of Strategic Cost-Saving Measures Expected To Save Over $2 Mln Annually
Brief: Scorpius Holdings Announces Partnership With U.S. Biotech Company